Teva Pharmaceutical Industries (TEVA) Current Deferred Tax Assets (2009 - 2015)

Teva Pharmaceutical Industries has disclosed Current Deferred Tax Assets across 7 years of filings, most recently posting $735.0 million for Q4 2015.

• Quarterly Current Deferred Tax Assets fell 25.98% year-over-year to $735.0 million in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $735.0 million (down 25.98% YoY) and the FY2015 annual result came in at $735.0 million, down 25.98% from the prior year.
• Current Deferred Tax Assets eased to $735.0 million in Q4 2015, from $993.0 million in the prior quarter.
• Over five years, Current Deferred Tax Assets peaked at $1.1 billion in Q4 2012 and troughed at $735.0 million in Q4 2015.
• A 5-year average of $984.0 million and a median of $993.0 million in 2014 frame the typical range for Current Deferred Tax Assets.
• Annual changes were most pronounced in 2011 — Current Deferred Tax Assets slumped 33.47% — and 2012, when it climbed 18.22%.
• Tracing TEVA's Current Deferred Tax Assets over 5 years: stood at $966.0 million in 2011, then grew by 18.22% to $1.1 billion in 2012, then slipped by 5.08% to $1.1 billion in 2013, then fell by 8.39% to $993.0 million in 2014, then fell by 25.98% to $735.0 million in 2015.
• Business Quant data shows TEVA's Current Deferred Tax Assets at $735.0 million in Q4 2015, $993.0 million in Q4 2014, and $1.1 billion in Q4 2013.